ACTIVE

Pathologies,Hématologie,Société Médicale Pascale Frére

Financial year 2025 · Closed on 30/06/2025

Net result14 k €+369,7 %over 1 year
Gross margin95,2 k €+28,9 %over 1 year
Equity19,1 k €-46,5 %over 1 year

Identity

Source · BCE/KBO

Pathologies,Hématologie,Société Médicale Pascale Frére is a Private limited company incorporated in 2009. Its main activity is: Specialist medical practice activities. Its registered office is in Nandrin.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0820.919.512
Incorporation
23/11/2009
Legal form
Private limited company
Registered office
Rue du Neufmoulin 9
4550 Nandrin · WallonieSee on map
Contributed capital
12 400,00 €
Latest accounts
30/06/2025
Signals
ProfitableLow riskPositive cashflowPositive EBITDA

Financials

Source · NBB, 16 filings

Trend over 16 financial years

20252024202320222021
Income statement
Gross margin95,2 k €73,9 k €75,4 k €65,5 k €56,7 k €
EBITDA94,2 k €72,4 k €74,3 k €63,1 k €55,2 k €
Operating result82,6 k €60,6 k €62,8 k €56,6 k €55 k €
Net result14 k €-5,2 k €4,2 k €-8,8 k €475,8 €
Balance sheet
Equity19,1 k €35,7 k €76,8 k €91,7 k €100,5 k €
Total assets120 k €113,9 k €135,8 k €151,1 k €119,2 k €
Cash57,9 k €44,2 k €45 k €52 k €50,7 k €
Debts100,5 k €77,8 k €56,8 k €59,1 k €15,4 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 2 ended

Active mandates

DirectorMandates in this companyPeriod
Pascale FRERE
Directorsince 01/12/2016Managersince 01/12/2016ended

Ended mandates

DirectorMandates in this companyPeriod
PAJEP0862.113.432Represented by Pascale FRERE
Manager23/11/2009 → 01/12/2016
Pathologies,Hématologie,Société Médicale Pascale Frére0820.919.512Represented by PASCALE FRERE
Manager

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date19/12/202503/02/202509/02/202430/01/202328/01/202228/01/2021
General meeting27/11/202528/11/202431/12/202330/12/202225/11/202126/11/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 16 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/06/202527/11/202519/12/2025FrenchPDF
Micro model30/06/202428/11/202403/02/2025FrenchPDF
Micro model30/06/202331/12/202309/02/2024FrenchPDF
Micro model30/06/202230/12/202230/01/2023FrenchPDF
Micro model30/06/202125/11/202128/01/2022FrenchPDF
Micro model30/06/202026/11/202028/01/2021FrenchPDF
Micro model30/06/201928/11/201907/01/2020FrenchPDF
Micro model30/06/201822/11/201807/02/2019FrenchPDF
Micro model30/06/201723/11/201712/01/2018FrenchPDF
Abridged model30/06/201624/11/201622/12/2016FrenchPDF
Abridged model30/06/201526/11/201523/12/2015FrenchPDF
Abridged model30/06/201425/11/201408/12/2014FrenchPDF
Abridged model30/06/201328/11/201304/12/2013FrenchPDF
Abridged model30/06/201222/11/201218/01/2013FrenchPDF
Abridged model30/06/201124/11/201120/12/2011FrenchPDF
Abridged model30/06/201025/11/201025/11/2010FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 2 ended

Active mandates

DirectorMandates in this companyPeriod
Pascale FRERE
Directorsince 01/12/2016Managersince 01/12/2016ended

Ended mandates

DirectorMandates in this companyPeriod
PAJEP0862.113.432Represented by Pascale FRERE
Manager23/11/2009 → 01/12/2016
Pathologies,Hématologie,Société Médicale Pascale Frére0820.919.512Represented by PASCALE FRERE
Manager

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates15/01/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates29/12/2016
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates31/03/2010
    DEMISSIONS, NOMINATIONS
    PDF
  • Other08/12/2009
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings16 filings
Mandates
Pascale FRERE
PAJEP
200920102011201220132014201520162017201820192020202120222023202420252026
Pathologies, Hématologie, Société Médicale Pascale Frère
Rue du Neufmoulin 9, 4550 Nandrin
Manager
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Rue du Neufmoulin 9, 4550 NandrinCurrent
accounts 2022 → 2025
Accounts 2025 · 2025-00585850

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Pathologies,Hématologie,Société Médicale Pascale FréreCurrent
CBE
PATHOLOGIES HEMATOLOGIE SOC MED PASCALE FRERE
accounts 2025
Accounts 2025 · 2025-00585850
Pathologies, Hématologie, Société Médicale Pascale Frère
accounts 2022 → 2024
Accounts 2024 · 2025-00023151

Events

  1. 2025
    Annual accounts 202514 k €↑
  2. 2025
    Name changePATHOLOGIES HEMATOLOGIE SOC MED PASCALE FRERE
  3. 2024
    Annual accounts 2024-5,2 k €↓
  4. 2023
    Annual accounts 20234,2 k €↑
  5. 2022
    Annual accounts 2022-8,8 k €↓
  6. 2021
    Annual accounts 2021475,8 €↓
  7. 2020
    Annual accounts 202030,6 k €↓
  8. 2019
    Annual accounts 201935,9 k €↑
  9. 2018
    Annual accounts 20186,5 k €↓
  10. 2017
    Annual accounts 201713,6 k €↑
  11. 2016
    Annual accounts 20167,5 k €↑
  12. 2015
    Annual accounts 2015753 €↑
  13. 2014
    Annual accounts 2014-1,5 k €↓
  14. 2013
    Annual accounts 20132 k €↑
  15. 2012
    Annual accounts 2012-9,1 k €↓
  16. 2011
    Annual accounts 20111,2 k €↑
  17. 2010
    Annual accounts 20107 €
  18. 23/11/2009
    IncorporationPrivate limited company